SOLACI-CACI 2024 – Day 2 Presentations

Discover the highlights of the second day of activities of  SOLACICACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. 

  • Dr. Juan Granada (USA) – “TAVR Role in Moderate AS: Current State and Future Perspectives”
  • Dr. Alaide Chieffo (ITA) – “Impella in the Real World: is it the Best Alternative?”
  • Dr. Santiago Ordoñez (ARG) – “Complications in CTO procedure”
  • Dr. Santiago Ordoñez (ARG) – “Present and future of CTO PCI?”
  • Dr. Sebastian Peralta (ARG) – “Left Main Disease”
  • Dr. Matías Rodriguez-Granillo (ARG) – “Analysis of coronary ulcers: are they all the same? When to treat them?”
  • Dr. José Martín Rabellino (ARG) – “Classification of Treatment for Common Femoral Artery Lesions”
  • Dr. Expedito Ribeiro (ARG) – “LM IVUS lesion analysis, when is it significant?”
  • Dr. Sebastián Peralta (ARG) – “LMCA Revascularization in Fragile Elderly Patients”
  • Dr. Lucio Padilla (ARG)– “HOW TO ANALYSE LESIONS IN BIFURCARTIONS”
  • Dr. Gastón A. Rodriguez Granillo (ARG) – “The Role of CTA and MRI in the Workup of ACS”
  • Dr. Pablo Spaletra (ARG)– “Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Has It Become Common?”
  • Dra. Sanali Paiva (BRA) – “Role of FFR in Defining the Need to Intervene in the Side Branch in the Treatment of True Bifurcations”
  • Dr. Pablo Mascolo (ARG) – “When do we consider a lesion to be non-obstructive: by angiography or angioCT”
  • Dr. Carlos E Uribe (COL) – “Latin American Bifurcation Club LATAMBif: Where we are”
  • Dr. Nicolás Zaderenko (ARG) – “When two stents? Definition of complete bifurcation and results of bifurcation stent”
  • Dr. Mauricio Zuñiga (COL) – “Latin American Consensus on the Percutaneous Treatment of Coronary Bifurcation Lesions”

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....